Stem Cell-Derived Exosomes: Natural Intercellular Messengers with Versatile Mechanisms for the Treatment of Diabetic Retinopathy
Yameng Song,Caiyun Yin,Ning Kong
DOI: https://doi.org/10.2147/ijn.s475234
IF: 7.033
2024-10-25
International Journal of Nanomedicine
Abstract:Yameng Song, 1, 2 Caiyun Yin, 2 Ning Kong 1 1 Department of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, Changchun, People's Republic of China; 2 National Health Commission (NHC) Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, People's Republic of China Correspondence: Ning Kong, Email Diabetic retinopathy is one of the complications of diabetes mellitus that occurs in the early stages. It is a disease that has a serious impact, and may lead to blindness when the disease progresses to advanced stages. Currently, treatments for diabetic retinopathy are mainly limited to its advanced stages of the disease, being restricted to a single therapeutic mechanism. Stem cells hold the promise of regenerative therapy and have the potential to comprehensively improve diabetic retinopathy. However, direct stem cell therapy carries some risk of carcinogenesis. Exosomes secreted by stem cells have shown a similar overall improvement in disease as stem cells. Exosomes can carry a number of biologically active materials from donor cells to recipient cells or distant organs, regulating intercellular signaling. Exosomes have shown remarkable efficacy in alleviating oxidative stress, inhibiting inflammatory responses, suppressing angiogenesis, reducing apoptosis and protecting neural tissues. Currently, the experimental literature using stem cell exosomes in the treatment of diabetic retinopathy tends to converge on the above experimental results. With this in mind, we have chosen to explore exosomes in depth from a subtle molecular perspective. We will elaborate on this perspective in this paper and propose to advocate exosome therapy as one promising approach for the treatment of diabetic retinopathy to ameliorate the lesions through multiple mechanisms. Keywords: stem cell, exosomes, diabetic retinopathy, versatile mechanisms, treatment According to data from the 10th edition of the International Diabetes Federation (IDF) Diabetes Atlas, an estimated 537 million adults aged 20–79 currently live with diabetes worldwide. This number is projected to reach 783 million by 2045, signifying a major global public health challenge. 1 Diabetes, fundamentally a metabolic disorder, is typically characterized by hyperglycemia (HG). While the disease itself is not inherently painful, the persistent hyperglycemic state over time can lead to a multitude of complications. Research indicates that diabetes primarily manifests as macrovascular and microvascular diseases, as well as specific neuropathies. These complications significantly impact patients' quality of life and can even reduce life expectancy in some cases. 2 Among these complications, diabetic retinopathy (DR) is regarded as one of the most prevalent manifestations in the progression of diabetes. The presence of DR indicates that the microcirculation has already been compromised by the diabetic milieu, making it a reliable biomarker of the detrimental effects of diabetes on an individual. 3,4 It is a leading cause of moderate to severe vision loss globally. 5 Between 1990 and 2020, DR was the only cause of blindness with an increasing global age-standardized prevalence. As the number of individuals with diabetes continues to rise and life expectancy increases, the burden of DR is expected to grow, leading to more cases of vision impairment and even blindness, thereby further diminishing the quality of life for affected individuals. 6,7 This pressing issue underscores the importance of emphasizing the prevention and treatment of DR. Despite the array of available treatment modalities, whether surgical or pharmaceutical, their limitations are substantial, offering only symptomatic relief without providing a comprehensive cure. 8–10 Exploring new treatment methods is crucial. Stem cell regenerative therapy holds promise as a feasible method for multi-mechanism treatment of DR. 11 Stem cells are capable of infinite renewal, producing at least one highly differentiated offspring. 12 Many stem cell therapies are rapidly advancing, including those for treating acquired immune deficiency syndrome, restoring vision from blindness, reversing spinal cord injury, and treating other disorders affecting motor neurons and demyelinating cells. 13 Mesenchymal stem cells (MSCs), a broad class of cells derived from tissues such as bone marrow, umlibical cord blood, adipose tissue, and dental pulp, have demonstrated remarkable potential and significant impact on retinal regeneration and repair after injury. For example, they have been shown to improve the regeneration of retinal ganglion cells (RGCs) to alleviate retinal neurodegeneration. 14 Clinical research on st -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology